Omega Healthcare Investors (OHI) to Release Earnings on Wednesday

Omega Healthcare Investors (NYSE:OHI) is anticipated to issue its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect the company to announce earnings of $0.79 per share and revenue of $287.1840 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 5, 2026 at 10:00 AM ET.

Omega Healthcare Investors Stock Performance

NYSE:OHI opened at $43.01 on Tuesday. The stock has a market cap of $12.71 billion, a P/E ratio of 24.03, a PEG ratio of 1.41 and a beta of 0.57. The company has a quick ratio of 7.11, a current ratio of 7.11 and a debt-to-equity ratio of 0.95. The business’s 50-day moving average price is $44.54 and its two-hundred day moving average price is $42.54. Omega Healthcare Investors has a twelve month low of $35.04 and a twelve month high of $46.36.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 17th. Investors of record on Monday, February 9th will be paid a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 6.2%. The ex-dividend date of this dividend is Monday, February 9th. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 149.72%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Royal Bank Of Canada boosted their price target on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 6th. BMO Capital Markets cut Omega Healthcare Investors from an “outperform” rating to a “market perform” rating and set a $45.00 target price on the stock. in a research note on Friday, January 9th. Citigroup restated a “buy” rating and set a $50.00 price target (up previously from $45.00) on shares of Omega Healthcare Investors in a research report on Wednesday, November 12th. UBS Group upped their price objective on Omega Healthcare Investors from $50.00 to $51.00 and gave the stock a “buy” rating in a report on Thursday, January 8th. Finally, Wells Fargo & Company lowered Omega Healthcare Investors from an “overweight” rating to an “equal weight” rating and reduced their price objective for the company from $48.00 to $45.00 in a research report on Thursday, January 29th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $46.82.

Insider Buying and Selling

In other news, CEO C Taylor Pickett purchased 20,000 shares of the stock in a transaction that occurred on Wednesday, November 5th. The stock was bought at an average cost of $43.14 per share, for a total transaction of $862,800.00. Following the acquisition, the chief executive officer directly owned 20,000 shares of the company’s stock, valued at $862,800. This represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CIO Vikas Gupta purchased 11,500 shares of the company’s stock in a transaction on Thursday, November 6th. The shares were purchased at an average cost of $42.97 per share, with a total value of $494,155.00. Following the transaction, the executive directly owned 13,773 shares in the company, valued at $591,825.81. This trade represents a 505.94% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 1.50% of the stock is owned by insiders.

Institutional Trading of Omega Healthcare Investors

A number of institutional investors have recently modified their holdings of OHI. CIBC Private Wealth Group LLC raised its position in Omega Healthcare Investors by 85.8% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 9,296 shares of the real estate investment trust’s stock valued at $392,000 after purchasing an additional 4,292 shares during the last quarter. CIBC Bancorp USA Inc. purchased a new position in shares of Omega Healthcare Investors during the third quarter valued at approximately $3,273,000. Captrust Financial Advisors raised its holdings in shares of Omega Healthcare Investors by 9.0% during the third quarter. Captrust Financial Advisors now owns 63,922 shares of the real estate investment trust’s stock valued at $2,699,000 after acquiring an additional 5,293 shares in the last quarter. Coldstream Capital Management Inc. lifted its stake in Omega Healthcare Investors by 2.4% in the third quarter. Coldstream Capital Management Inc. now owns 62,382 shares of the real estate investment trust’s stock worth $2,634,000 after acquiring an additional 1,458 shares during the period. Finally, Danske Bank A S bought a new stake in Omega Healthcare Investors in the third quarter valued at $84,000. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.